Trial Profile
Study investigating effect of Belatacept in Lupus Nephritis patient who underwent renal transplant
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2018
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 23 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting